Shares of Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) have been given a consensus rating of “Buy” by the five brokerages that are covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation, three have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokers that have covered the stock in the last year is $317.50.
NUTX has been the subject of a number of analyst reports. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, July 28th. Wall Street Zen downgraded shares of Nutex Health from a “buy” rating to a “hold” rating in a research note on Saturday, September 5th. Lake Street Capital restated a “buy” rating and issued a $310.00 target price (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. B Riley reaffirmed a “buy” rating on shares of Nutex Health in a report on Friday, September 4th. Finally, Zacks Research upgraded shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, August 24th.
Get Our Latest Stock Analysis on Nutex Health
Insider Buying and Selling
Hedge Funds Weigh In On Nutex Health
A number of institutional investors have recently modified their holdings of the business. Allworth Financial LP lifted its position in shares of Nutex Health by 41.0% during the 2nd quarter. Allworth Financial LP now owns 203 shares of the company’s stock worth $35,000 after buying an additional 59 shares during the last quarter. Kilter Group LLC bought a new position in Nutex Health in the second quarter valued at about $27,000. VIRGINIA RETIREMENT SYSTEMS ET Al grew its position in Nutex Health by 3.7% in the fourth quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 5,600 shares of the company’s stock valued at $922,000 after acquiring an additional 200 shares during the last quarter. Islay Capital Management LLC acquired a new position in Nutex Health during the fourth quarter worth about $34,000. Finally, Corient Private Wealth LP raised its stake in Nutex Health by 5.1% during the second quarter. Corient Private Wealth LP now owns 6,684 shares of the company’s stock worth $1,142,000 after acquiring an additional 325 shares in the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.
Nutex Health Trading Down 2.6%
Shares of NASDAQ:NUTX opened at $208.79 on Monday. The business’s 50 day simple moving average is $179.58 and its 200 day simple moving average is $143.77. Nutex Health has a 1 year low of $83.99 and a 1 year high of $224.28. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96. The company has a market capitalization of $1.43 billion, a P/E ratio of 8.20 and a beta of 0.28.
Nutex Health (NASDAQ:NUTX – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating the consensus estimate of $4.95 by $4.43. The firm had revenue of $210.75 million during the quarter, compared to analysts’ expectations of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. On average, research analysts anticipate that Nutex Health will post 27.58 EPS for the current fiscal year.
About Nutex Health
Nutex Health Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, outpatient facilities and physician practices. The company focuses on delivering emergency, inpatient and outpatient care through community-based healthcare facilities, including micro-hospitals designed to provide essential hospital services in convenient local settings.
Its services may include emergency medicine, primary care, specialty care, diagnostic testing, imaging, laboratory services and other ancillary healthcare offerings.
Recommended Stories
- Five stocks we like better than Nutex Health
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
